Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Enrichment of retinal ganglion and Müller glia progenitors from retinal organoids derived from human induced pluripotent stem cells - possibilities and current limitations

Research output: Contribution to journalJournal articleResearchpeer-review

  • Kristine Karla Freude
  • Sarkis Saruhanian
  • Alanna McCauley
  • Colton Paterson
  • Madeleine Odette
  • Annika Oostenink
  • Poul Hyttel
  • Mark Gillies
  • Henriette Haukedal
  • Miriam Kolko
View graph of relations

BACKGROUND: Retinal organoids serve as excellent human-specific disease models for conditions affecting otherwise inaccessible retinal tissue from patients. They permit the isolation of key cell types affected in various eye diseases including retinal ganglion cells (RGCs) and Müller glia.

AIM: To refine human-induced pluripotent stem cells (hiPSCs) differentiated into three-dimensional (3D) retinal organoids to generate sufficient numbers of RGCs and Müller glia progenitors for downstream analyses.

METHODS: In this study we described, evaluated, and refined methods with which to generate Müller glia and RGC progenitors, isolated them via magnetic-activated cell sorting, and assessed their lineage stability after prolonged 2D culture. Putative progenitor populations were characterized via quantitative PCR and immunocytochemistry, and the ultrastructural composition of retinal organoid cells was investigated.

RESULTS: Our study confirms the feasibility of generating marker-characterized Müller glia and RGC progenitors within retinal organoids. Such retinal organoids can be dissociated and the Müller glia and RGC progenitor-like cells isolated via magnetic-activated cell sorting and propagated as monolayers.

CONCLUSION: Enrichment of Müller glia and RGC progenitors from retinal organoids is a feasible method with which to study cell type-specific disease phenotypes and to potentially generate specific retinal populations for cell replacement therapies.

Original languageEnglish
JournalWorld Journal of Stem Cells
Volume12
Issue number10
Pages (from-to)1171-1183
Number of pages13
ISSN1948-0210
DOIs
Publication statusPublished - 26 Oct 2020

ID: 61991331